Jump Financial LLC Buys 280,650 Shares of Alignment Healthcare, Inc. $ALHC

Key Points

• Jump Financial LLC increased its holdings in Alignment Healthcare by 266.8%, acquiring an additional 280,650 shares, bringing its total ownership to 385,850 shares valued at approximately $7.2 million.
• Alignment Healthcare reported a 49% increase in quarterly revenue year-over-year, with earnings per share of $0.07, which beat analysts' expectations.
• Institutional investors collectively own 86.19% of Alignment Healthcare's stock, indicating strong institutional confidence in the company.

Jump Financial LLC grew its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 266.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 385,850 shares of the company's stock after buying an additional 280,650 shares during the period. Jump Financial LLC owned 0.20% of Alignment Healthcare worth $7,185,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ALHC. Wells Fargo & Company MN raised its stake in Alignment Healthcare by 58.3% during the 4th quarter. Wells Fargo & Company MN now owns 48,813 shares of the company's stock valued at $549,000 after purchasing an additional 17,985 shares during the period. Raymond James Financial Inc. bought a new stake in Alignment Healthcare during the 4th quarter valued at approximately $1,769,000. Barclays PLC raised its stake in Alignment Healthcare by 3.7% during the 4th quarter. Barclays PLC now owns 200,564 shares of the company's stock valued at $2,256,000 after purchasing an additional 7,118 shares during the period. MetLife Investment Management LLC increased its stake in Alignment Healthcare by 5.6% in the 4th quarter. MetLife Investment Management LLC now owns 61,344 shares of the company's stock worth $690,000 after acquiring an additional 3,256 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its stake in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after acquiring an additional 6,286 shares during the last quarter. Institutional investors own 86.19% of the company's stock.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 180,000 shares of the company's stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $13.41, for a total value of $2,413,800.00. Following the completion of the sale, the chief executive officer directly owned 1,553,100 shares in the company, valued at approximately $20,827,071. This represents a 10.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction on Monday, July 14th. The stock was sold at an average price of $13.44, for a total value of $403,200.00. Following the completion of the sale, the president owned 2,042,899 shares of the company's stock, valued at $27,456,562.56. This represents a 1.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 636,185 shares of company stock worth $9,235,468 over the last quarter. 7.00% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ALHC. Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and lifted their price objective for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. UBS Group lifted their price objective on Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Finally, Zacks Research raised Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $18.83.

Alignment Healthcare Trading Up 0.2%

ALHC traded up $0.04 during trading hours on Friday, reaching $16.36. 1,760,791 shares of the company's stock traded hands, compared to its average volume of 2,964,395. The firm has a 50-day moving average price of $13.93 and a 200 day moving average price of $15.34. Alignment Healthcare, Inc. has a 52-week low of $8.65 and a 52-week high of $21.06. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The firm has a market capitalization of $3.24 billion, a PE ratio of -58.43 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. During the same quarter in the previous year, the business earned ($0.13) EPS. Alignment Healthcare's revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, sell-side analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.